ZIC
AGIO icon

ZWJ Investment Counsel’s Agios Pharmaceuticals AGIO Stock Holding History

ZWJ Investment Counsel’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-171,982
Closed -$6.02M – 162
2020
Q3 		$6.02M Sell
171,982
-3,630
-2% -$159K 0.48% 50
2020
Q2 		$9.39M Buy
175,612
+15,970
+10% +$739K 0.81% 41
2020
Q1 		$5.66M Buy
159,642
+2,267
+1% +$105K 0.51% 48
2019
Q4 		$7.51M Buy
157,375
+40,966
+35% +$1.55M 0.51% 55
2019
Q3 		$3.77M Buy
116,409
+31,180
+37% +$1.29M 0.29% 59
2019
Q2 		$4.25M Buy
+85,229
New +$4.56M 0.33% 58

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ZWJ Investment Counsel's AGIO Position: Q4 2020 in Review

ZWJ Investment Counsel sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 171,982 shares — an estimated $6.02M sold.

ZWJ Investment Counsel first reported a position in AGIO in Q2 2019 and held it in 6 quarters. The position peaked at $9.39M in Q2 2020. 200 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • ZWJ Investment Counsel reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • ZWJ Investment Counsel sold 171,982 Agios Pharmaceuticals shares in Q4 2020, an estimated $6.02M.
  • ZWJ Investment Counsel first reported a position in Agios Pharmaceuticals in Q2 2019 and held it in 6 quarters.
  • ZWJ Investment Counsel's Agios Pharmaceuticals position peaked at $9.39M in Q2 2020.
  • 200 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on ZWJ Investment Counsel's 13F filing for Q4 2020, filed 26 Feb 2021.